Orlistat CAS 96829-58-2 API Miisaanka lumin Nadiifnimada Daawada 98.0 ~ 101.5%
Shanghai Ruifu Chemical Co., Ltd. waa soo saaraha ugu horreeya ee Orlistat (CAS: 96829-58-2) oo leh tayo sare leh, wax soo saar ganacsi, daroogo miisaan lumis.Kiimikada Ruifu waxay bixin kartaa gaarsiinta adduunka oo dhan, qiimo tartan ah, adeeg aad u wanaagsan, tiro yar iyo tiro badan oo la heli karo.Iibso Orlistat,Please contact: alvin@ruifuchem.com
Magaca Kiimikada | Orlistat |
La mid ah | N-Formyl-L-Leucine (1S)-1-[[(2S,3S)-3-Hexyl-4-Oxo-2-Oxetanyl]Methyl] Dodecyl Ester;(S)-2-Formylamino-4-Methyl-Pentanoic Acid (S) -1-[[(2S,3S) -3-Hexyl-4-Oxo-2-Oxetanyl] Methyl] - Dodecyl Ester;Tetrahydrolipstatin;Ro-18-0647 |
Lambarka CAS | 96829-58-2 |
Heerka Saamiyada | Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan |
Qaanuunka molecular | C29H53NO5 |
Miisaanka Molecular | 495.75 |
Meesha dhalaalaysa | 43.0 ℃ ~ 48.0 ℃ |
Cufnaanta | 0.976±0.06 g/cm3 |
Xasaasi ah | Xasaasida kulaylka |
Solubility | Ku milmay chloroform |
Xaalada Maraakiibta | Heerkulka deegaanka hoostiisa |
COA & MSDS | La heli karo |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Caddaan ama ku dhawaad cad budada crystalline |
Aqoonsiga A | Nuugista Infrared |
Aqoonsiga B | Waqtiga haynta ee ugu sarreeya ee ugu sarreeya ee xalka Tusaalaha wuxuu u dhigmaa midka xalka Heerka, sida lagu helay Assay. |
Daahirnimada / Habka Falanqaynta | 98.0 ~ 101.5% ee C29H53NO5, lagu xisaabiyey ku salaysan anhydrous, dareere-free |
Wareeg gaar ah | -48.0° ~ -51.0° |
Go'aaminta Biyaha | ≤0.20% |
Hadhaaga dabka | ≤0.10% |
Biraha culus | ≤20pm |
Isku dhafka Orlistat La Xiriira A | ≤0.20% |
Isku dhafka Orlistat ee la xidhiidha B | ≤0.05% |
Formylleucinea | ≤0.20% |
Isku dhafka Orlistat ee C | ≤0.05% |
Orlistat Open Ring Epimer | ≤0.20% |
D-Leucine Orlistat | ≤0.20% |
Nijaasnimo Shakhsiyeed Aan La Aqoonsan | ≤0.10% |
Isku dhafka Orlistat ee D | ≤0.20% |
Orlistat Open Ring Amide | ≤0.10% |
Isku dhafka Orlistat La Xiriira E | ≤0.20% |
Wadarta wasakhda | ≤1.00% |
Heerka Imtixaanka | Farmashiyaha Shiinaha;USP35 |
Isticmaalka | Walaxda Farmashiyeedka Firfircoon (API) |
Xidhmada:Dhalo, bacda bireed ee aluminium, 25kg/Drum kartoonada, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Weelka si adag u xidh oo ku kaydi qabow, qalalan (2 ~ 8 ℃) iyo bakhaar hawo wanaagsan leh oo ka fog walxaha aan ku habboonayn.Ka fogow iftiinka xooggan iyo kulaylka, qoyaanka.
Rarida:Ku gaarsii adduunka oo dhan hawo, by FedEx/DHL Express.Bixi keenid degdeg ah oo la isku halayn karo.
Orlistat waa nooc cusub oo caalami ah oo la aqoonsan yahay oo ah daroogada dhimista miisaanka.Magaceeda ganacsi waa Sainike waxaana markii ugu horeysay lagu iibiyaa New Zealand 1998. Orlistat waa mudo dheer oo wax ku ool ah oo gaar ah oo xakameynaya lipase caloosha iyo mindhicirka, waana mid aan lagu milmin biyaha, ku milma chloroform, oo si fudud u milmi kara ethanol.Orlistat waxaa loo isticmaali karaa kiliinikada si loo daaweeyo buurnaanta.Caadi ahaan, qiyaasta 120mg ayaa la qaataa saddex jeer maalintii hal saac gudahooda cuntada.Miisaanka oo yaraada wuxuu bilaabmaa inuu dhaco laba toddobaad ka dib isticmaalka.Waxaa si joogto ah loo isticmaali karaa 6-12 bilood, saameynteeduna way joogsan doontaa inay kordhiso ka dib marka qiyaasta maalinlaha ah ay dhaafto 400mg.Daawadani waxay ku habboon tahay in lagu daro cunto kaloriin yar oo ay isticmaalaan shakhsiyaadka cayilan iyo kuwa cayilan, waxaana sidoo kale loo isticmaali karaa daaweyn waqti dheer ah bukaanada la kulmay arrimo halis ah oo la xiriira miisaanka.Orlistat waxay leedahay saamayn-xakamaynta miisaanka muddada-dheer kaas oo yareeya oo ilaaliya miisaanka kana hortagaya dib u soo noqoshada.Isticmaalka Orlistat waxay hoos u dhigi kartaa dhacdooyinka khatarta ah ee la xidhiidha miisaanka iyo cudurrada, oo ay ku jiraan hypercholesterolemia, nooca-2 diabetes, dulqaadka gulukooska ee daciifka ah, hyperinsulinemia, iyo hypertension, waxayna yareyn kartaa dufanka ku jira xubnaha.Orlistat waxay sidoo kale hagaajisaa heerarka dufanka dhiigga: waxay hoos u dhigi kartaa serum triglycerides (TG) iyo kolestaroolka cufnaanta hoose ee lipoprotein (LDL-C), waxayna kordhin kartaa saamiga lipoproteins cufnaanta sare ilaa lipoproteins cufnaanta hoose ee bukaannada cayilan.
Orlistat
C29H53NO5 495.73
l-Leucine, N-formyl-, 1-[(3-hexyl-4-oxo-2-oxetanyl) methyl] dodecyl ester, [2S-[2 (R*), 3]]-;
N-Formyl-l-leucine, ester leh (3S,4S) -3-hexyl-4-[(2S) -2-hydroxytridecyl]-2-oxetanone [96829-58-2].
Qeexitaan
Orlistat waxa uu ka kooban yahay NLT 98.0% iyo NMT 101.5% ee C29H53NO5, oo lagu xisaabiyo anhydrous, bilaa dareere ah.
AQOONSIGA
• A. Nuugista Infrared <197M>
B. Wakhtiga haynta ee ugu sarraysa ee xal muunadu waxay u dhigantaa kan xalalka caadiga ah, sida lagu helay Assay.
ASSAY
Habka
[Xusuusin-Ka fogow isticmaalka caagagga caaga ah ee diyaarinta ama xakamaynta xal kasta ee falanqayntan.]
Marxaladda wareega: Acetonitrile, fosfooraska acid, iyo biyaha (860: 0.05: 140)
Xalka caadiga ah: 0.5 mg/mL ee USP Orlistat RS ee wajiga mobilada.Isku durka ka dib diyaarinta ama ku kaydi 5.
Xalka muunada: 0.5 mg/mL ee Orlistat ee wajiga mobilada.Isku durka ka dib diyaarinta ama ku kaydi 5.
Nidaamka Chromatographic
(Fiiri Chromatography <621>, Habboonaanta Nidaamka.)
Habka: LC
Baaraha: UV 195
Tiirka: 3.9-mm × 15-cm;4-µm xirmo L1
Heerka socodka: 1.0 ml/min
Cabbirka duritaanka: 20 µL
Ku habboonaanta nidaamka
Tusaale: Xalka caadiga ah
Shuruudaha ku habboonaanta
Qiyaasta heerka qaraabada: NMT 2.0%
Falanqaynta
Tusaalooyinka: Xalka caadiga ah iyo xalalka muunada
Xisaabi boqolkiiba orlistat (C29H53NO5) ee qaybta Orlistat ee la qaatay:
Natiijadu = (rU/rS) × (CS/CU) × 100
rU = jawaabta ugu sarreysa ee xalka Tusaalaha
rS = jawaabta ugu sarreysa ee xalalka caadiga ah
CS = diiradda USP Orlistat RS ee xalka caadiga ah (mg/mL)
CU = uruurinta Orlistat ee xalka Tusaalaha (mg/mL)
Shuruudaha aqbalaadda: 98.0% -101.5% ku salaysan anhydrous, dareere-free
XANUUNKA
wasakhda aan noolaha ahayn
• Hadhaaga dabka <281>: NMT 0.1%
• Biraha culus, Habka II <231>: 20 ppm
Waxyeellada dabiiciga ah
Habka 1: Xadka Orlistat La Xiriira Isku-dhafka A
Xalka caadiga ah: 0.1 mg/mL ee USP Orlistat La Xiriira Isku-dhafka A RS ee acetone
Xalka muunada: 50 mg/mL of Orlistat in acetone
Nidaamka Chromatographic
(Fiiri Chromatography <621>, Chromatography-ka-dhuuban.)
Habka: TLC
Adsorbent: 0.25-mm lakabka silica jel chromatographic ah
Codsiga mugga: 10µL
Horumarinta nidaamka dareeraha: Toluene iyo ethyl acetate (4: 1)
Xalka ogaanshaha: Ku wareeji 2.5 g oo ah phosphomolybdic acid iyo 1 g oo ah sulfate ceric sulfate 100-mL galaas mug leh, ku milmi oo ku milmi methanol ilaa mugga.
Falanqaynta
Tusaalooyinka: Xalka caadiga ah iyo xalalka muunada
Saxanka ka saar, oo si fiican u qalaji.Ku buufi saxan qallalan oo leh xal ogaanshaha, oo saxanka ku rid foornada 120 30 daqiiqo.
Shuruudaha aqbalaadda: Meel kasta oo labaad oo ka socota xalka Tusaalaha ee u dhigma orlistat-ka laxiriira xayndaabka A kama badna meesha u dhiganta ee xalinta caadiga ah (0.2%).
Habka 2: Xadka Orlistat La Xiriira Isku-dhafka B
Xalka caadiga ah: 0.025 mg/mL ee USP Orlistat Isku-xidhka B RS ee methylene chloride
Xalka muunada: 50 mg/mL of Orlistat in methylene chloride
Xalka muunada sped: 50 mg/mL ee Orlistat ee xalalka caadiga ah
Nidaamka Chromatographic
(Fiiri Chromatography <621>, Habboonaanta Nidaamka.)
Qaabka: GC
Baaraha: ionization ololka
Tiirka: 0.32-mm x 30-m silica isku dhafan, oo lagu dahaadhay weji taagan 0.25-µm G27
Heerkulka tiirka: Eeg shaxda barnaamijka heerkulka hoose.
Heerkulka Hore () Heerkulka Sare (/min) Heerkulka ugu dambeeya
50 4 170 -
170 30 300 30
Heerkulka
Durida: 270
Baadiye: 280
Gaasta qaada: Helium
Heerka socodka: 30 ml/min
Saamiga kala baxa: 10:1
Cabbirka duritaanka: 2µL
Ku habboonaanta nidaamka
Tusaale: Xalka caadiga ah
Shuruudaha ku habboonaanta
Qiyaasta heerka qaraabada: NMT 10.0%
Falanqaynta
Tusaalooyinka: Xalka muunada iyo xal muunada sped
Xisaabi boqolleyda Orlistat laxiriira xayndaabka B ee qaybta Orlistat ee la qaatay:
Natiijadu = [rU/(rSP rU)] × (CS/CT) × 100
rU = jawaabta ugu sarreysa ee orlistat-ka laxiriirta xayndaabka B ee xalka Tusaalaha
rSP = jawaabta ugu sarreysa ee orlistat laxiriirta xayndaabka B ee ka imanaya muunada muunada Spiked
CS = fiirsashada USP Orlistat Isku dhafka B RS ee xalka caadiga ah (mg/mL)
CT = fiirsashada Orlistat ee xalka muunada Spiked (mg/mL)
Shuruudaha aqbalaadda: NMT 0.05% ee iskudarka Orlistat ee B waa la helay.
Habka 3
[Xusuusin-Ka fogow isticmaalka caagagga caaga ah ee diyaarinta ama xakamaynta xal kasta ee falanqayntan.]
Marxaladda wareegta, xalalka caadiga ah, iyo xal muunad: U diyaari sida lagu faray Imtixaanka.
Xalka ku habboonaanta nidaamka: 10 µg/mL ee USP Orlistat RS, 0.1 µg/mL ee USP Orlistat La xidhiidha Isku-dhafka C RS, iyo 0.25 µg/mL ee USP Orlistat Compound D RS ee wejiga moobilka
Nidaamka Chromatographic
(Fiiri Chromatography <621>, Habboonaanta Nidaamka.)
U wad sida lagu faray Assay, marka laga reebo chromatograph-ka xalka ku habboonaanta nidaamka.
Ku habboonaanta nidaamka
Tusaalaha: Xalka ku habboonaanta nidaamka
Shuruudaha ku habboonaanta
Saamiga calaamad-ilaa-sanqad: NLT 3 ee xarunta orlistat ee laxiriirta C iyo iskudarka laxiriira D ee ugu sarreeya
Qiyaasta heerka qaraabada: NMT 10.0% ee heerka ugu sarreeya ee orlistat
Falanqaynta
Tusaalooyinka: Xalka caadiga ah iyo xalalka muunada
Xisaabi boqolkiiba wasakh kasta ee qaybta Orlistat ee la qaatay:
Natiijadu = (rU/rS) × (CS/CU) × (1/F) × 100
rU = jawaabta ugu sarraysa ee qof kasta oo nijaas ah oo ka yimid xalka Tusaalaha
rS = jawaabta ugu sarreysa ee USP Orlistat RS oo ka timid xalalka caadiga ah
CS = diiradda USP Orlistat RS ee xalka caadiga ah (mg/mL)
CU = uruurinta Orlistat ee xalka Tusaalaha (mg/mL)
F = jawaab celin qaraabo ah sida lagu sheegay Shaxda 1
Shuruudaha aqbalaadda: eeg Shaxda 1aad ee wasakhnimada.
Shaxda wasakhaysan 1
Magaca Wakhtiga Haynta Qaraabada Shuruudaha Ogolaanshaha Qodobbada Jawaabta Qaraabo, NMT (%)
Formylleucinea 0.10 4.0 0.2
Xarunta laxiriirta Orlistat C 0.13 33 0.05
Orlistat giraanta furan ee epimerb 0.44 1.0 0.2
Xarunta Orlistat laxiriirta D* 0.90 - Lagu xisaabiyay gudaha
Habka 4
Orlistat giraanta furan amidec* 0.90 - Waxaa lagu xisaabiyay gudaha
Habka 4
Orlistat 1.00 - -
d-Leucine orlistatd 1.18 1.0 0.2
Nijaasnimada shakhsi ahaaneed ee aan la aqoonsan - 1.0 0.1
* Coelutes ee nidaamkan LC, lagu go'aamiyay iyadoo la isticmaalayo Habka 4.
N-Formyl-l-leucine.
b (2S,3R,5S)-5-[(S)-2-Formylamino-4-methyl-pentanoyloxy]-2-hexyl-3-hydroxy-hexadecanoic acid.
c N-Formyl-l-leucine (S)-1-[(2S,3S)-2-hydroxy-3-[1-phenyl-R-ethylcarbomoyl]nonyl]-dodecyl ester.
d N-Formyl-d-leucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl] dodecyl ester ama enantiomer.
Habka 4: Xadka Isku-dhafka Orlistat ee D
Marxaladda guurguura: Methanol iyo biyaha (83:17)
Xalka ku habboonaanta nidaamka: 4 mg/mL ee USP Orlistat RS iyo 2.4 µg/mL ee USP Orlistat Compound D RS ee acetonitrile, siday u kala horreeyaan
Xalka caadiga ah: 5.0 mg/mL ee USP Orlistat RS ee acetonitrile
Xalka muunada: 5.0 mg/mL of Orlistat in acetonitrile
Nidaamka Chromatographic
(Fiiri Chromatography 621, Habboonaanta Nidaamka.)
Habka: LC
Baaraha: 205 nm
Tiirka: 4.0-mm × 25-cm;5-µm xirmo L7
Heerka socodka: 0.6 ml/min
Cabbirka duritaanka: 20 µL
Ku habboonaanta nidaamka
Tusaalaha: Xalka ku habboonaanta nidaamka
Shuruudaha ku habboonaanta
Saamiga calaamad-ilaa-sanqa: NLT 3 ee isku xidhka orlistat ee laxidhiidha D ugu sarreysa
Qiyaasta heerka qaraabada: NMT 10.0% ee heerka ugu sarreeya ee orlistat
Falanqaynta
Tusaalooyinka: Xalka caadiga ah iyo xalalka muunada
Xisaabi boqolkiiba wasakh kasta ee qaybta Orlistat ee la qaatay:
Natiijadu = (rU/rS) × (CS/CU) × (1/F) × 100
rU = jawaabta ugu sarraysa ee qof kasta oo nijaas ah oo ka yimid xalka Tusaalaha
rS = jawaabta ugu sarreysa ee USP Orlistat RS ee xalka caadiga ah
CS = fiirsashada USP Orlistat RS ee xalka caadiga ah (µg/mL)
CU = fiirsashada Orlistat ee xalka Tusaalaha (µg/mL)
F = jawaab celin qaraabo ah sida lagu helay Jaantuska wasakhnimada 2
Shuruudaha aqbalaadda: Fiiri Shaxda 2aad ee wasakhnimada.
Shaxda wasakhaysan 2
Magaca Wakhtiga Haynta Qaraabada Shuruudaha Ogolaanshaha Qodobbada Jawaabta Qaraabo, NMT (%)
Xarunta Orlistat ee la xidhiidha D 0.94 1.0 0.2
Orlistat 1.00 - -
Orlistat giraanta furan amidea 1.25 4.3 0.1
N-Formyl-l-leucine (S)-1-[(2S,3S)-2-hydroxy-3-[1-phenyl-R-ethylcarbomoyl]nonyl]-dodecyl ester.
Habka 5: Xadka Isku-dhafka Orlistat La Xiriira E
Buffer: 0.4 N xalinta borate, lagu hagaajiyay pH ee 10.2
Wakiilka soo saarida: o-Phthaldehyde (OPA) xal.[Xusuusin-Haddii aan la heli karin ganacsi ahaan, wakiilka Derivitizing waxaa loo diyaarin karaa 1% mid kasta oo ah 3-mercaptopropionic acid iyo o-phthaldialdehyde ee 0.4M borate borate solution.]
Xalka A: Ku wareeji 4.1 g oo ah sodium acetate trihydrate iyo 40 mg ee ethylenediaminetetraacetic acid (EDTA) oo ku shub weel 1-L ah.Ku milmi 950 mL oo biyo ah, kuna hagaaji 0.1 N sodium hydroxide una beddel pH ah 7.2.Ku qas biyo ilaa mugga, ku dar 2.5 mL oo tetrahydrofuran ah, oo qas.Shaandhee, iyo degas.
Xalka B: Ku wareeji 2.7 g oo ah sodium acetate trihydrate iyo 40 mg ee EDTA galka mugga 1-L.Ku milmi 200 ml oo biyo ah, kuna hagaaji 0.1 N sodium hydroxide una beddel pH 7.2 ah.Ku dar 800 mL oo ah acetonitrile, filter, iyo degas.
Marxaladda guurguura: Eeg shaxda gradient ee hoose.
Waqtiga (min) Xalka A (%) Xalka B (%)
0 96.7 3.3
20 60 40
24 0 100
38 0 100
38 96.7 3.3
45 96.7 3.3
Xalka caadiga ah: Ku wareeji tiro miisaan ah oo ku saabsan 0.2 mg ee USP Orlistat Laxiriirta iskudarka E RS 20-mL dhalo-madaxeed.Ku dar 10 ml oo ah 4 N sodium hydroxide, oo xidh fiilada.Kuleyli fiishka ilaa 100 ilaa 1 saac, ka dibna u ogolow inaad ku qaboojiso heerkulka qolka.Ku wareeji 2 mL ee xalka ka soo baxay galaas mug leh oo 50-mL ah, oo ku qas biyo ilaa mugga.Ilaa 0.5 mL ee xalkan ku dar 2.0 ml oo Buffer ah iyo 0.5 mL oo ah wakiilka soo saarida.
Xalka Tusaalaha: Ku sii soco sida lagu faray xalinta caadiga ah, laakiin taa beddelkeeda isticmaal 25 mg Orlistat si aad u bedesho 0.2 mg ee USP Orlistat La Xiriira Isku-dhafka E RS.
Nidaamka Chromatographic
(Fiiri Chromatography <621>, Habboonaanta Nidaamka.)
Habka: LC
Dareemiyaha: Fluorescence 340 nm (xariir);450 nm
Tiirarka
Ilaalada: 2.1-mm × 2-cm;50-µm xirmo L1
Falanqaynta: 2.1-mm × 20-cm;xirxiran L1
Heerka socodka: 0.5 ml/min
Cabbirka duritaanka: 20 µL
Ku habboonaanta nidaamka
Tusaale: Xalka caadiga ah
Shuruudaha ku habboonaanta
Isbeddelka heerka qaraabada ah: NMT 6.0% ee qaybta E ugu sarreysa ee Orlistat
Falanqaynta
Tusaalooyinka: Xalka caadiga ah iyo xalalka muunada
Xisaabi boqolkiiba wasakhnimadan qaybta Orlistat ee la qaatay:
Natiijadu = (rU/rS) × (CS/CU) × 100
rU = jawaabta ugu sarreysa ee orlistat laxiriirta E ee xalka Tusaalaha
rS = jawaabta ugu sarreysa ee USP Orlistat Isku-xidhka E RS ee xalka caadiga ah
CS = fiirsashada USP Orlistat Isku dhafka E RS ee xalka caadiga ah (mg/mL)
CU = uruurinta Orlistat ee xalka Tusaalaha (mg/mL)
Shuruudaha aqbalaadda
Nijaasnimada shaqsiga ah: NMT 0.2% ee walaxda la xidhiidha Orlistat E waa la helay.
Wadarta wasakhda: NMT 1.0% wadarta wasakhda ayaa la helay, natiijooyinka habraacyada 1, 2, 3, 4, iyo 5 waa lagu daray.
IMTIXAANO GAAR AH
• Wareegga indhaha, Wareegga Gaarka ah <781>
Xalka muunada: 30 mg/mL ee khamriga fuuqbaxay
Shuruudaha aqbalaadda: Inta u dhaxaysa -48.0 iyo -51.0, at 20
• Go'aaminta Biyaha, Habka Ic <921>: NMT 0.2%
SHURUUD DHEERAAD AH
Baakadaha iyo Kaydinta: Ku kaydi weelasha si fiican u xidhan inta u dhaxaysa 2 iyo 8℃.
• Heerarka Tixraaca USP <11>
USP Orlistat RS
Isku dhafka USP Orlistat La Xiriira A RS
Isku dhafka USP Orlistat La Xiriira B RS
Isku dhafka USP Orlistat La Xiriira C RS
Isku dhafka USP Orlistat La Xiriira D RS
Isku dhafka USP Orlistat La Xiriira E RS
USP35